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Abstract
Background and Aims: In HIV-infected patients, mani-
festations of the disease are common in the gastroin-
testinal tract. The objective of our study was to evalu-
ate the diagnostic yield of the Givenﾮ Video Capsule
System (Given Imaging, Yoqneam, Israel) in these pa-
tients.
Methods: After exclusion of GI-tract stenosis by
anamnestic exploration, 49 patients were included into
the study. Stratification: Group A (n = 19): HIV-posi-
tive, CD4 cell count < 200/ﾵl, gastrointestinal symp-
toms present. Group B: HIV-positive, CD4 < 200/ﾵl,
without gastrointestinal symptoms (n = 19 Group) C:
healthy volunteers (n = 11).
Results: In group A there was a total of 30 pathologi-
cal findings, 15 of which with therapeutic implications.
In group B, there was a total of 22 pathological find-
ings, 5 relevant for therapy. In group C there was a to-
tal of 13 pathological findings, 3 with therapeutic rele-
vance. In 89% (group A) vs. 26% (group B), patholog-
ical findings were detected distal the ligament of
Treitz (p = 0.001). All capsules were recovered with-
out complications after 12 to 96 h from the stool.
Conclusion: Wireless capsule endoscopy of the small
intestine should be considered for HIV-infected pa-
tients with marked immunosuppression and gastroin-
testinal symptoms.
INTRODUCTION
The lymphoid tissue of the gut harbors most of the T-
lymphocytes of the body and plays an important role
as the first line of defense against viral, bacterial, para-
sitic and fungal pathogens [1, 2]. Therefore, the gas-
trointestinal tract is particularly susceptible to infec-
tions resulting from CD4 cell depletion associated with
HIV infection [3]. Since the introduction of highly ac-
tive antiretroviral therapy (HAART), the frequency of
opportunistic infections of the gastrointestinal tract
has fallen dramatically. However, despite the adminis-
tration of HAART there are still patients developing
opportunistic infections of the gastrointestinal tract.
Depending on the study population, the incidence is
about 10 % [4]. Low adherence, resistance to HAART
and low bioavailability of antiretroviral drugs may play
an important role in the pathophysiology of oppor-
tunistic infections in the HAART era. Furthermore,
many protease inhibitors cause diarrhea as a side effect
[5]. Among the infectious agents causing gastrointesti-
nal abnormalities in HIV patients are: Salmonella spp.,
atypical Mycobacteria such as Mycobacterium avium in-
tracellulare (MAI), Escherichia coli, Shigella spp. and
Campylobacter spp., Candida spp., Cytomegalovirus
(CMV) and Herpes simplex virus (HSV) [5, 6, 7]. Cryp-
tosporidium, Microsporidium and Giardia are distributed
worldwide. Entamoeba histolytica and Strongyloides
stercoralis are mainly of tropical origin, but can be
transmitted by sexual contact [5]. HIV infected pa-
tients without gastrointestinal symptoms often have
minor abnormalities of villous architecture, character-
istically a mild villous atrophy associated with either
crypt hypoplasia or hyperplasia. To a lesser extent,
these changes are seen in HIV-negative individuals as
well. Invasive diagnostic procedures such as endoscopy
are necessary for the diagnosis of gastrointestinal dis-
orders, but most part of the small bowel until recently
was not accessible to conventional endoscopy. The ob-
jective of our study was to evaluate the diagnostic yield
of the Givenﾮ Video Capsule System (Given Imaging,
Yoqneam, Israel) in HIV-positive patients with and
without gastrointestinal symptoms and its therapeutic
implications. The wireless endoscopy is meanwhile well
established as a diagnostic tool in occult gastrointesti-
nal bleeding when colonoscopy and gastro-duo-
denoscopy fail to identify the bleeding site.
PATIENT CHARACTERSTICS AND METHODS
Between March 2002 and December 2004, 49 patients
were included in our study prospectively and were di-
vided into three groups. Group A consisted of HIV-
positive patients with a CD4 cell count of < 200/ﾵl
and gastrointestinal symptoms such as diarrhea or ab-
dominal pain [n = 19, age 45.7 ﾱ 9.8 years (range 31-
61), m:f 16:3, CD4 cells 78.1 ﾱ 59.9/ﾵl (range 1-187)].
Group B consisted of HIV-positive patients with a
CD4 cell count < 200/ﾵl, but without GI symptoms [n
= 19, age 43.7 ﾱ 9.7 years (range 30-63), m:f 15:4,
CD4 cells 118.3 ﾱ 51.9/ﾵl (10-196)]. Group C were
healthy volunteers (n = 11, age 36.8 ﾱ 4.2 years (range
31-44), m:f 6:5) without any gastrointestinal symp-
toms.
All patients ingested the capsule after an overnight
fast, without a complete colon preparation. Patients
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tion, abdominal operation, diabetes, pacemaker im-
plantation or pregnancy. Patients ingested the capsule
in the morning and remained in the clinic throughout
the recording. All patients swallowed the capsule with-
out problems and the procedure was well tolerated.
They were allowed to drink clear fluids at 2 hours and
to consume a light meal at 4 hours after ingestion of
the capsule. The recorder was disconnected at about 8
hours after the beginning of the study. The patients
were requested to verify the natural excretion of the
capsule in the stool.
The Given M2A video capsule system (Given Imag-
ing Ltd., Yoqneam, Israel) is a new method of direct
visualization of the small bowel that provides nonin-
vasive examination of areas of the gut that are not ac-
cessible through conventional endoscopy. It allows the
visual investigation of the small bowel.
The study received approval by the local institution-
al review board, informed written consent was ob-
tained by the participants.
RESULTS
The procedure was well tolerated and there were no
complications. All capsules were recovered after 12 to
96 h in the stool. In group A [CD4 cell count < 200/ﾵl
with gastrointestinal symptoms] the pathological find-
ings were (n): Villous atrophy (6), antrum gastritis (5),
ulcerative jejunitis (3), apthous jejunal lesion (2), brun-
neromas (2), jejunal Kaposi sarcoma (2), aphthous
duodenal lesion (1) bulbitis (1), duodenal mucosal ul-
cer (1), follicular hyperplasia in terminal ileum (1), gas-
tral mucosal ulcer (1), jejunal angiodysplasia (1), jejunal
mycobacteriosis (1), jejunitis (1), reflux esophagitis (1),
and Strongyloides stercoralis infection (1). Twelve pa-
tients had lymphangiectatic villi of the small intestine.
In group A there was a total of 30 pathological results,
17 of these distal of the ligament of Treitz and 15
with therapeutic relevance. The diagnosis was accom-
plished by capsule endoscopy in 9 cases, where regular
endoscopic evaluation would not have reached the site
within the small intestine. In four cases the capsule did
not pass the ileocoecal valve within the recorded time
period due to reduced peristalsis.
In group B [CD4 cell count < 200/ﾵl without GI
symptoms] the following diagnoses were found (n):
Antrum gastritis (4), gastric mucosal ulcer (4), duo-
denitis (3), reflux esophagitis (2), villous atrophy (2),
brunneroma (1), colitis (1), duodenal mucosal ulcer
(1), follicular hyperplasia within the terminal ileum (1),
jejunal polyp (1), jejunitis (1), and suspected jejunal an-
giodysplasia (1). Six patients had lymphangiectatic villi
in the small intestine. In group B, there was a total of
22 pathological findings, 5 of these distal of the liga-
ment of Treitz and 5 with therapeutic relevance. Two
patients had no pathological findings. In seven
patients the capsule did not reach the ileocoecal valve
within the recording period. In group B there the
number of patients with lymphangiectatic villi and
villous atrophy was lower as compared to group A
(6 vs. 12).
Finally, in group C [healthy volunteers] we found
antrum gastritis (3), brunneromas (2), bulbitis (1), hy-
pertensive gastropathy (1), ileitis (1), jejunal lipoma (1),
jejunal polyp (1), pseudodiverticulum (1), suspected je-
junal angiodysplasias (1), villous atrophy (1). Sporadic
lymphangiectatic villi were seen in five patients. In
group C there were a total of 13 pathological results, 5
of these distal to the ligament of Treitz and 3 with
therapeutic relevance (suspected jejunal angiodysplasia
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Table 1. Comparsion of the groups A, B and C. Group A: HIV positive, CD4 cell count < 200/ﾵl, gastrointestinal symptoms
present. Group B: HIV positive, CD4 < 200/ﾵl, without gastrointestinal symptoms. Group C: healthy volunteers.
Group n Age CD4 cell Number of Pathological findings Pathological findings
(m/f) (year) count (/ﾵl) pathological proximal of the ligament distal of the ligament
findings of Treitz of Treitz
A 19 46 ﾱ 10 78 ﾱ 60 30 13 (68%) 17 (89%)
(HIV-positive) (16/3) (31–61) (1-187)
B 19 44 ﾱ 10 118 ﾱ 52 22 17 (89%) 5 (26%)
(HIV-positive) (15/4) (30-63) (10-196)
C
(HIV-negative) 11 37 ﾱ 4 - 13 8 (73%) 5 (45%)
(6/5) (31-44)
Fisherﾴs exact test:
Pathological findings proximal of the ligament of Treitz:
Group A vs Group B; p = 0.232
Group A vs Croup C; p = 1.000
Group B vs Group C; p = 0.327
Pathological findings distal of the ligament of Treitz :
Group A vs Group B; p = 0.001
Group A vs Croup C; p = 0.028
Group B vs Group C; p = 0.425
Fig. 1. Strongyloides stercoralis.
Fig. 2. Mycobacterium avium infection..
Fig. 3. Villous atrophy.
Fig. 4. Ulcerative jejunitis.
Fig. 5. Kaposi sarcoma.
Fig. 6. Lymphangiectatic villi.
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2. Oette:Umbruchvorlage  23.04.2009  9:43 Uhr  Seite 193(1), jejunal polyp (1), ileitis (1). In one case the capsule
did not reach the coecum during the examination.
DISCUSSION
Opportunistic infections and tumors of the gastroin-
testinal tract play an important role in clinical manage-
ment of AIDS patients. The data presented in this
study show that capsule endoscopy reveals a substan-
tial variety of manifestations in the small bowel in
HIV-positive patients with advanced immunosuppres-
sion. There were significantly more pathological find-
ings distal of the ligament of Treitz in the group pre-
senting with gastrointestinal symptoms (group A) than
in the group B without gastrointestinal symptoms, in
particular more severe findings like Kaposi sarcoma,
ulcerative jejunitis due to CMV-infection, aphthous je-
junal lesions, jejunal mycobacteriosis, Strongyloides
stercoralis infection and jejunitis. This was valid espe-
cially for patients with CD4 cell count less than
100/ﾵl. Accordingly, therapeutic implications were
more frequent in group A compared to group B pa-
tients. The number of pathological findings proximal
of the ligament of Treitz and the total amount of
findings are nearly identical in both HIV positive
groups.
Interestingly, group C (healthy volunteers) showed
several unexpected pathological findings. The small in-
testine might harbour certain conditions, which are be-
yond the reach of conventional diagnostic procedures
and therefore there are certain conditions where it is
hard to distinguish between normal and pathological
findings. To confirm these findings, further investiga-
tions with the wireless capsule endoscopy should fol-
low to investigate the small bowel under physiological
conditions. Despite the absence of underlying HIV-
disease in group C, the pathological findings of the
small intestine like suspected jejunal angiodysplasias,
jejunal polyp, ileitis, villous atrophy were similar as in
group B.
Our study shows that capsule endoscopy is well tol-
erated and provides diagnostic information of the
small intestine, which cannot be obtained by conven-
tional endoscopy. The quantitative amount of patho-
logical findings was comparable in both HIV positive
groups, however, there were more severe pathological
findings in the group with further progressed disease.
Several limitations of the study should be taken
into account. Firstly, the sample size is small and thus
may not be generalized for the whole HIV-infected
population. Secondly, due to the cost of the capsules,
the technique is not suitable in settings with limited re-
sources. Moreover, as contemporary antiretroviral
therapy is capable of controlling clinical manifesta-
tions of immunosuppression, the findings of the
study may only be valid for a small subgroup of HIV-
patients (so called late presenters without antiviral
treatment). Finally, unspecific findings of capsule en-
doscopy may not be regarded as HIV-associated dis-
ease. Further studies are necessary to clarify the rele-
vance of the spectrum of pathological results.
Despite limited size of study population, we could
show that wireless capsule endoscopy of the small in-
testine provides additional information, and influences
therapeutic planning in HIV-positive patients with a
CD4 cell count of less than 200/ﾵl and GI-symptoms.
This had therapeutic consequences in approximately
20% of the patients, when gastrointestinal symptoms
were present. Thus, capsule endoscopy should be fur-
ther evaluated in regard of its use for the management
of HIV-infected patients with immunosuppression.
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